The measurement of fluid deposition in humans foll... [Pediatrics. 1971]

Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve. [Pediatrics. 1972]
Evaluation of mist tent therapy in cystic fibrosis using maximum expiratory flow volume curve.
Motoyama EK, Gibson LE, Zigas CJ. Pediatrics. 1972 Aug; 50(2):299-306.
An evaluation of nightly mist tent therapy for patients with cystic fibrosis. [Am Rev Respir Dis. 1973]
An evaluation of nightly mist tent therapy for patients with cystic fibrosis.
Chang N, Levison H, Cunningham K, Crozier DN, Grosett O. Am Rev Respir Dis. 1973 Apr; 107(4):672-5.
Alterations in airway dynamics following inhalation of ultrasonic mist. [Chest. 1972]
Alterations in airway dynamics following inhalation of ultrasonic mist.
Malik SK, Jenkins DE. Chest. 1972 Dec; 62(6):660-4.
Review Editorial: Mists and aerosols: new studies, new thoughts. [J Pediatr. 1974]
Review Editorial: Mists and aerosols: new studies, new thoughts.
Taussig LM. J Pediatr. 1974 Apr; 84(4):610-22.
Review Aerosol therapy in patients with cystic fibrosis. [Schweiz Med Wochenschr. 1997]
Review Aerosol therapy in patients with cystic fibrosis.
Schöni MH, Nikolaizik WH. Schweiz Med Wochenschr. 1997 Feb 1; 127(5):158-64.

Minimum alveolar concentrations and hemodynamic effects of two different preparations of sevoflurane in pigs. [Clinics (Sao Paulo). 2010]
Minimum alveolar concentrations and hemodynamic effects of two different preparations of sevoflurane in pigs.
Otsuki DA, Fantoni DT, Holms C, Auler JO Jr. Clinics (Sao Paulo). 2010 May; 65(5):531-7.
Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis. [Thorax. 1980]
Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.
Weller PH, Ingram D, Preece MA, Matthew DJ. Thorax. 1980 Jan; 35(1):42-6.
Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis. [Arch Dis Child. 1974]
Influence of mist tent therapy on sputum viscosity and water content in cystic fibrosis.
Rosenbluth M, Chernick V. Arch Dis Child. 1974 Aug; 49(8):606-10.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

The measurement of fluid deposition in humans following mist tent therapy.
The measurement of fluid deposition in humans following mist tent therapy.
Pediatrics. 1971 Oct ;48(4):605-12.

PubMed
Bacterial infection in cystic fibrosis.
Bacterial infection in cystic fibrosis.
Arch Dis Child. 1972 Dec ;47(256):908-13.

PubMed
The variable effect of a bronchodilating agent on pulmonary function in cystic f...
The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis.
J Pediatr. 1973 May ;82(5):863-8.

PubMed
Meconium-ileus equivalent in a 15-year-old patient with mucoviscidosis.
Meconium-ileus equivalent in a 15-year-old patient with mucoviscidosis.
Acta Paediatr. 1962 May ;51:344-8.

PubMed
Nocturnal mist therapy in cystic fibrosis.
Nocturnal mist therapy in cystic fibrosis.
Practitioner. 1971 Jun ;206(236):786-90.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed